Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Sea 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
obesity
obesity
Page 4 of 12
Retail
Denmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By
Naomi Kresge
and
Bloomberg
May 2, 2024
Retail
Novo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark
By
Sanne Wass
,
Naomi Kresge
and
Bloomberg
May 1, 2024
Health
No evidence Ozempic and Wegovy raise risk of self harm, EU regulators said
By
Jonel Aleccia
and
The Associated Press
April 13, 2024
Health
The saga of ‘Ozempig’: Minor league baseball team ripped for fat-shaming with insensitive mascot name
By
Scott McFettridge
and
The Associated Press
March 29, 2024
Politics
‘Outrageous’: Bernie Sanders has Ozempic demands after study says it costs just $5 per month to manufacture
By
Madison Muller
,
Robert Langreth
and
Bloomberg
March 28, 2024
Health
Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5
By
Madison Muller
,
Robert Langreth
and
Bloomberg
March 28, 2024
Aging Well
Is Medicare keeping pace with our aging population? Experts say ‘we need to double down and go faster’
By
Liz Seegert
March 26, 2024
Health
You could pay for Wegovy with Medicare, but there’s a catch
By
Jonel Aleccia
and
The Associated Press
March 22, 2024
Health
The foundation behind Ozempic maker Novo Nordisk is funding an Nvidia-backed AI supercomputer project
By
Chris Morris
and
Prarthana Prakash
March 20, 2024
Retail
Rebel investors want KitKat maker Nestlé to cut back on junk food—but the fortunes of its Mindful Chef brand suggest customers aren’t ready for a health kick
By
Ryan Hogg
March 14, 2024
Health
What are the risks of having a baby after 35? An expert explains the reality of advanced maternal age
By
Jordyn Bradley
March 10, 2024
Health
7 habits that can help you lose weight—and keep it off—according to experts
By
Rachel Reiff Ellis
March 2, 2024
Health
A billion people worldwide are obese and Ozempic and other weight-loss drugs aren’t a solution, WHO says
By
Naomi Kresge
,
Angela Feliciano
and
Bloomberg
March 1, 2024
Leadership
Oprah to leave WeightWatchers board, donating her stake over ‘perceived conflict of interest around her taking weight loss medications’
By
Amanda Gerut
February 29, 2024
Lifestyle
Novo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results
By
Prarthana Prakash
February 27, 2024
Most Popular
Success
Amazon founder Jeff Bezos says ‘millions of people’ will be living in space by 2045—and robots will commute on our...
By
Orianna Rosa Royle
Success
Billionaire boss of South Korean construction giant is encouraging his workers to have children with a $75,000 bonus
By
Orianna Rosa Royle
Success
Meta is hiring entry-level roles that pay up to $290,000 a year and require little prior experience
By
Emma Burleigh